Circulating Tumor Cell (CTC) Analysis: An unrealized strategy for cancer diagnosis, monitoring, and treatment

Analysis of circulating tumor cells (CTCs) from liquid biopsy samples can provide detailed genomic, physiological and biomarker data of cancer status and progression. ​

Explore this interview article with cancer researcher and CTC core lab manager, Mouadh Barbirou, MSc PhD, Thomas Jefferson University, to gain insight about:

• Available CTC capture methods from blood and other liquid biopsy types, and which strategies work best for different cancer types
• The roles that CTCs currently play in clinical oncology research
• What is yet needed to integrate liquid biopsy CTC capture and analysis into mainstream clinical practice for cancer diagnosis, monitoring, and treatment.